Jordan Park Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-21,823
Closed -$2.02M 49
2021
Q2
$2.02M Sell
21,823
-178
-0.8% -$15.1K 0.11% 32
2021
Q1
$1.95M Buy
+22,001
New +$2.18M 0.12% 25

Other funds holding ARKG

Jordan Park Group's ARKG Position: Q3 2021 in Review

Jordan Park Group sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 21,823 shares — an estimated $2.02M sold.

Jordan Park Group first reported a position in ARKG in Q1 2021 and held it in 2 quarters. The position peaked at $2.02M in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Jordan Park Group reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Jordan Park Group sold 21,823 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $2.02M.
  • Jordan Park Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 2 quarters.
  • Jordan Park Group's ARK Genomic Revolution ETF position peaked at $2.02M in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Jordan Park Group's 13F filing for Q3 2021, filed 19 Oct 2021.